A US federal appeals court has overturned the Federal Trade Commission’s “click to cancel” rule. The rule would have made it easier for consumers to cancel subscriptions by requiring companies to provide a straightforward way to cancel subscriptions and recurring charges and would have made it illegal to prevent cancellation through retention offers or long call center wait times.

Delaware House Bill 162 unsurprisingly passed the House last week—but the real fight lies ahead in the Senate. As it moves forward, it’s vital that lawmakers hear directly from those who stand to lose the most: Delaware’s direct sellers.

The Delaware House passed HB 162 by a vote of 27-11. The legislation, which the DSA described as “an unprecedented threat to the direct selling business model,” has led to intense pushback from the direct selling community.

The Direct Selling Association stated that Delaware House Bill 162 poses what it calls “a critical threat to direct selling,” and proposes regulations that it calls “impractical, unnecessary and unlike any imposed elsewhere in the United States.”

Avon Products Inc. announced significant developments in its bankruptcy proceedings.  A comprehensive settlement and asset sale has been approved and, as of March 5, the company has emerged from Chapter 11 with a clear path forward.

Plexus Worldwide announced it has received a patent from the US Patent Office for its product Immune +. The plant-based supplement was designed by the company’s in-house Research and Development team to support the body’s defense system.